11/20 Enanta Pharma misses by $0.27, beats on revenue •Enanta Pharma (NASDAQ:ENTA): Q4 EPS of $1.86 misses by $0.27. •Revenue of $75.9M (+491.1% Y/Y) beats by $2.78M. https://seekingalpha.com/news/3313610-enanta-pharma-misses-0_27-beats-revenue?uprof=51#email_link